Venom 3 is once more at the highest of the box office while Tom Hanks' film is struggling

“Venom: The Last Dance” I enjoyed one other weekend at the highest of the box office. The Sony release starring Tom Hardy increased ticket sales by $26.1 million, based on studio estimates Sunday.

It was a comparatively quiet weekend for North American cinemas within the run-up to the presidential election. The charts were dominated by major studio holdovers like “Venom 3.” “The Wild Robot” and “Smile 2,” while audiences firmly rejected the reunion of Tom Hanks, Robin Wright and Robert Zemeckis “Here.” Thirty years after “Forrest Gump,” “Here” opened in 2,647 locations for just $5 million.

“Venom 3” only fell 49% in its second weekend, which is a remarkably small decline for a superhero film It didn't exactly open either. In two weeks, the film grossed over $90 million domestically; The first two opened to over $80 million. Globally, the image is looking higher as the corporate has already crossed the $300 million threshold.

Now Universal and Illumination's “The Wild Robot” continues to attract moviegoers after six weeks (and when available on video-on-demand), taking second place with $7.6 million. That's 11% greater than last weekend. The animated charmer has earned over $121 million in North America and $269 million worldwide.

“'The Wild Robot' was quietly the fall season's absolute hit,” said Paul Dergarabedian, senior media analyst at Comscore. “It’s amazing that this film is seeing an increase after six weeks.”

“Smile 2” got here in third with $6.8 million, helping push its worldwide total to $109.7 million.

The contemporary graphic novel “Here,” adapted from “Forrest Gump” screenwriter Eric Roth, was financed by Miramax and distributed by Sony’s TriStar. With a permanently installed camera, it takes the audience through the years in a lounge. The critics didn't agree: Overall, the rating on Rotten Tomatoes is a miserable 36%.

“It was a quiet weekend anyway, but it didn't have the reception that many expected,” said Dergarabedian. “There are a lot of films for the audience that 'Here' was looking for.”

Although “Here” played in nearly 1,000 additional locations, it landed behind Focus Features’ papal thriller “Conclave,” which grossed $5.3 million. “Conclave” opened in 1,796 theaters, down just 20% from its debut last weekend, and has grossed $15.2 million to this point. Two Indian movies also made it into the highest 10 of their debuts: “Bhool Bhulaiyaa 3” and “Singham Again”.

Total box office returns remain nearly 12% behind 2023. But holiday moviegoing will likely give the industry a lift because the 12 months ends, with titles like “Gladiator II” and “Wicked” on the best way.

“It will be a lot more competitive in a few weeks,” Dergarabedian said.

Jesse Eisenberg film “A real pain” a comedic drama about cousins ​​on a Holocaust tour in Poland, which premiered in 4 theaters in New York and Los Angeles this weekend. Revenue was an estimated $240,000 or $60,000 per screen, which was among the many three highest per-theater averages of the 12 months. Searchlight Pictures will expand the well-reviewed film nationwide in the approaching weeks, opening in over 800 theaters on November fifteenth.

However, the cinema charts don’t all the time give an entire picture of the cinema landscape. This weekend, several relatively high-profile movies in theaters didn’t record full box office returns for various reasons, including Clint Eastwood's film “Juror No. 2” Steve McQueen's film about World War II “Flash” and the Cannes darling “Emilia Perez.” Netflix, which oversees “Emilia Pérez,” never reports box office figures. Apple Original Films is following suit with “Blitz,” a possible awards contender that can hit theaters before hitting Apple TV+ on November twenty second.

“Juror No. 2” is a Warner Bros. release and a well-reviewed one at that. Directed by Eastwood, the film stars Nicholas Hoult as a juror in a murder case who faces a serious moral dilemma. Domestic ticket sales were held back. The studio said it earned $5 million from international screenings, where it played on 1,348 screens.

Even major studios occasionally withhold box office returns. At the start of the 12 months, Disney didn’t report on the Daisy Ridley film “Young woman and the sea.” Results have been withheld, particularly throughout the COVID-19 pandemic.

“It’s really up to the dealers,” Dergarabedian said. “The reason why certain films go unreported is often because there is a possibility that the quality of the film is related to the box office.”

The final domestic figures might be published on Monday. Estimated ticket sales for Friday through Sunday in U.S. and Canadian theaters, based on Comscore, were:

1. “Venom: The Last Dance,” $26.1 million.

2. “The Wild Robot,” $7.6 million.

3. “Smile 2,” $6.8 million.

4. “Conclave,” $5.3 million.

5. “Here,” $5 million.

6. “We Live In Time,” $3.5 million.

7. “Terrifier 3,” $3.4 million.

8. “Singham Again,” $2.1 million.

9. “Beetlejuice Beetlejuice,” $2.1 million.

10. “Bhool Bhulaiyaa 3,” $2.1 million.

___

Originally published:

image credit : www.mercurynews.com